Cargando…

Influenza B: Prospects for the Development of Cross-Protective Vaccines

In this review, we analyze the epidemiological and ecological features of influenza B, one of the most common and severe respiratory infections. The review presents various strategies for cross-protective influenza B vaccine development, including recombinant viruses, virus-like particles, and recom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsybalova, Liudmila M., Stepanova, Liudmila A., Ramsay, Edward S., Vasin, Andrey V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228933/ https://www.ncbi.nlm.nih.gov/pubmed/35746794 http://dx.doi.org/10.3390/v14061323

Ejemplares similares

Plant-Produced Recombinant Influenza A Virus Candidate Vaccine Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin
por: Blokhina, Elena A., et al.
Publicado: (2020)

Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine
por: Tsybalova, Liudmila M., et al.
Publicado: (2018)

Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors
por: Mardanova, Eugenia S., et al.
Publicado: (2015)

Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection
por: Zykova, Anna A., et al.
Publicado: (2023)

Plant-Produced Nanoparticles Based on Artificial Self-Assembling Peptide Bearing the Influenza M2e Epitope
por: Blokhina, Elena A., et al.
Publicado: (2023)

Highly Immunogenic Nanoparticles Based on a Fusion Protein Comprising the M2e of Influenza A Virus and a Lipopeptide
por: Zykova, Anna A., et al.
Publicado: (2020)

Comparative Immunological Study in Mice of Inactivated Influenza Vaccines Used in the Russian Immunization Program
por: Shanko, Andrei, et al.
Publicado: (2020)

Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin
por: Stepanova, Liudmila A., et al.
Publicado: (2015)

Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes
por: Stepanova, Liudmila A., et al.
Publicado: (2018)

Flagellin-Fused Protein Targeting M2e and HA2 Induces Innate and T-Cell Responses in Mice of Different Genetic Lines
por: Stepanova, Liudmila A., et al.
Publicado: (2022)

Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents
por: Kiselev, O. I., et al.
Publicado: (2015)

Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets
por: Kiseleva, Irina, et al.
Publicado: (2018)

Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein
por: Kotlyarov, R.Y., et al.
Publicado: (2010)

A Fusion Protein Based on the Second Subunit of Hemagglutinin of Influenza A/H2N2 Viruses Provides Cross Immunity
por: Stepanova, L. A., et al.
Publicado: (2016)

Changes in RNA secondary structure affect NS1 protein expression during early stage influenza virus infection
por: Baranovskaya, Irina, et al.
Publicado: (2019)

Efficient Transient Expression of Recombinant Proteins in Plants by the Novel pEff Vector Based on the Genome of Potato Virus X
por: Mardanova, Eugenia S., et al.
Publicado: (2017)

Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity
por: Li, Zhuofan, et al.
Publicado: (2021)

Prospects and Challenges in the Development of Universal Influenza Vaccines
por: Madsen, Anders, et al.
Publicado: (2020)

Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development
por: Staneková, Zuzana, et al.
Publicado: (2010)

Comparative Economic Evaluation of Haemophilus influenzae Type b Vaccination in Belarus and Uzbekistan
por: Griffiths, Ulla K., et al.
Publicado: (2011)

Recombinant Influenza Vaccines
por: Sedova, E.S., et al.
Publicado: (2012)

Microbial and Genetic Resources for Cobalamin (Vitamin B12) Biosynthesis: From Ecosystems to Industrial Biotechnology
por: Balabanova, Larissa, et al.
Publicado: (2021)

Prospects of and Barriers to the Development of Epitope-Based Vaccines against Human Metapneumovirus
por: Stepanova, Ekaterina, et al.
Publicado: (2020)

The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections
por: Lozhkov, Alexey A., et al.
Publicado: (2020)

Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model
por: Rudenko, Larisa, et al.
Publicado: (2018)

Comments on the mechanisms of action of radiation protective agents: basis components and their polyvalence
por: Vasin, Mikhail V
Publicado: (2014)

Protective Immunity Based on the Conserved Hemagglutinin Stalk Domain and Its Prospects for Universal Influenza Vaccine Development
por: Khanna, Madhu, et al.
Publicado: (2014)

Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses
por: Soema, Peter Christiaan, et al.
Publicado: (2015)

Influence of the Linking Order of Fragments of HA2 and M2e of the influenza A Virus to Flagellin on the Properties of Recombinant Proteins
por: Stepanova, L. A., et al.
Publicado: (2018)

Current state and future of 3D bioprinted models for cardiovascular research and drug development
por: Polonchuk, Liudmila, et al.
Publicado: (2021)

COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy
por: Domnich, Alexander, et al.
Publicado: (2022)

Cross-Protective Immune Responses Elicited by Live Attenuated Influenza Vaccines
por: Jang, Yo Han, et al.
Publicado: (2013)

Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines
por: Lee, Yu-Na, et al.
Publicado: (2015)

Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model
por: Stepanova, Ekaterina, et al.
Publicado: (2021)

Study of immunogenicity of recombinant proteins based on hemagglutinin and neuraminidase conservative epitopes of Influenza A virus
por: Dukhovlinov, Ilya, et al.
Publicado: (2013)

Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
por: Vasin, Andrey V, et al.
Publicado: (2023)

Influenza vaccination: protecting the most vulnerable
por: Tanner, Alex R., et al.
Publicado: (2021)

Discovery and Preclinical Development of Antigiardiasis Fumagillol Derivatives
por: Padia, Janak, et al.
Publicado: (2020)

Prenatal Programming of Neuroendocrine System Development by Lipopolysaccharide: Long-Term Effects
por: Izvolskaia, Marina, et al.
Publicado: (2018)

An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection
por: Ni, Yawei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_isuisuf9s2501iooh59g794tb8